Meta-analysis finds intranasal esketamine boosts remission in MDD and TRD fast, but side effects and short trials leave long-term questions.
Ayse K. Coskun, MD
Advertisement
Dr Coskun is a second-year psychiatry resident at Creighton University.
Articles by Ayse K. Coskun, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 7 - Interactive
2
Beyond Deprescribing: A Formula for Excellent Clinical Care
3
VY1706 for Treatment of Alzheimer Disease Shows Tau Reductions and Favorable Tolerability
4
AI Chatbots and the Erosion of Therapeutic Discomfort
5